These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23949777)

  • 1. Forced expression of indoleamine-2,3-dioxygenase in human umbilical cord-derived mesenchymal stem cells abolishes their anti-apoptotic effect on leukemia cell lines in vitro.
    Yuan Y; Lu X; Tao CL; Chen X; Shao HW; Huang SL
    In Vitro Cell Dev Biol Anim; 2013 Dec; 49(10):752-8. PubMed ID: 23949777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Umbilical cord mesenchymal stem cells inhibit the differentiation of circulating T follicular helper cells in patients with primary Sjögren's syndrome through the secretion of indoleamine 2,3-dioxygenase.
    Liu R; Su D; Zhou M; Feng X; Li X; Sun L
    Rheumatology (Oxford); 2015 Feb; 54(2):332-42. PubMed ID: 25169988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preconditioning with interleukin-1 beta and interferon-gamma enhances the efficacy of human umbilical cord blood-derived mesenchymal stem cells-based therapy via enhancing prostaglandin E2 secretion and indoleamine 2,3-dioxygenase activity in dextran sulfate sodium-induced colitis.
    Yu Y; Yoo SM; Park HH; Baek SY; Kim YJ; Lee S; Kim YL; Seo KW; Kang KS
    J Tissue Eng Regen Med; 2019 Oct; 13(10):1792-1804. PubMed ID: 31293088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of COX-2 but not indoleamine 2,3-dioxygenase-1 enhances the immunosuppressive ability of human umbilical cord-derived mesenchymal stem cells.
    Li D; Han Y; Zhuang Y; Fu J; Liu H; Shi Q; Ju X
    Int J Mol Med; 2015 May; 35(5):1309-16. PubMed ID: 25777747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive characterisation of large-scale expanded human bone marrow and umbilical cord mesenchymal stem cells.
    Mennan C; Garcia J; Roberts S; Hulme C; Wright K
    Stem Cell Res Ther; 2019 Mar; 10(1):99. PubMed ID: 30885254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Immunomodulatory Effect of Triptolide on Mesenchymal Stromal Cells.
    He H; Takahashi A; Mukai T; Hori A; Narita M; Tojo A; Yang T; Nagamura-Inoue T
    Front Immunol; 2021; 12():686356. PubMed ID: 34484183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis.
    Liu Y; Mu R; Wang S; Long L; Liu X; Li R; Sun J; Guo J; Zhang X; Guo J; Yu P; Li C; Liu X; Huang Z; Wang D; Li H; Gu Z; Liu B; Li Z
    Arthritis Res Ther; 2010; 12(6):R210. PubMed ID: 21080925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact.
    Ciccocioppo R; Cangemi GC; Kruzliak P; Gallia A; Betti E; Badulli C; Martinetti M; Cervio M; Pecci A; Bozzi V; Dionigi P; Visai L; Gurrado A; Alvisi C; Picone C; Monti M; Bernardo ME; Gobbi P; Corazza GR
    Stem Cell Res Ther; 2015 Jul; 6(1):137. PubMed ID: 26206376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Human umbilical cord mesenchymal stem cells with adenovirus-mediated interleukin 12 gene transduction inhibits the growth of ovarian carcinoma cells both in vitro and in vivo].
    Zhao WH; Cheng JX; Shi PF; Huang JY
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 May; 31(5):903-7. PubMed ID: 21602155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment of umbilical cord derived MSCs with IFN-γ and TNF-α enhances the tumor-suppressive effect on acute myeloid leukemia.
    Sun L; Wang J; Wang Q; He Z; Sun T; Yao Y; Wang W; Shen P
    Biochem Pharmacol; 2022 May; 199():115007. PubMed ID: 35307345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indoleamine 2,3-dioxygenase mediates inhibition of virus-specific CD8(+) T cell proliferation by human mesenchymal stromal cells.
    Hong J; Hueckelhoven A; Wang L; Schmitt A; Wuchter P; Tabarkiewicz J; Kleist C; Bieback K; Ho AD; Schmitt M
    Cytotherapy; 2016 May; 18(5):621-9. PubMed ID: 27008974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-γ regulates the function of mesenchymal stem cells from oral lichen planus via indoleamine 2,3-dioxygenase activity.
    Zhang Z; Han Y; Song J; Luo R; Jin X; Mu D; Su S; Ji X; Ren YF; Liu H
    J Oral Pathol Med; 2015 Jan; 44(1):15-27. PubMed ID: 25212102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially.
    Prasanna SJ; Gopalakrishnan D; Shankar SR; Vasandan AB
    PLoS One; 2010 Feb; 5(2):e9016. PubMed ID: 20126406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Mesenchymal Stem Cells-mediated Transcriptomic Regulation of Leukemic Cells in Delivering Anti-tumorigenic Effects.
    Sarmadi VH; Ahmadloo S; Boroojerdi MH; John CM; Al-Graitte SJR; Lawal H; Maqbool M; Hwa LK; Ramasamy R
    Cell Transplant; 2020; 29():963689719885077. PubMed ID: 32024378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A CD8 T cell/indoleamine 2,3-dioxygenase axis is required for mesenchymal stem cell suppression of human systemic lupus erythematosus.
    Wang D; Feng X; Lu L; Konkel JE; Zhang H; Chen Z; Li X; Gao X; Lu L; Shi S; Chen W; Sun L
    Arthritis Rheumatol; 2014 Aug; 66(8):2234-45. PubMed ID: 24756936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cells use IDO to regulate immunity in tumor microenvironment.
    Ling W; Zhang J; Yuan Z; Ren G; Zhang L; Chen X; Rabson AB; Roberts AI; Wang Y; Shi Y
    Cancer Res; 2014 Mar; 74(5):1576-87. PubMed ID: 24452999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a human umbilical cord-derived mesenchymal stromal cell-based advanced therapy medicinal product to treat immune and/or inflammatory diseases.
    Mebarki M; Iglicki N; Marigny C; Abadie C; Nicolet C; Churlaud G; Maheux C; Boucher H; Monsel A; Menasché P; Larghero J; Faivre L; Cras A
    Stem Cell Res Ther; 2021 Nov; 12(1):571. PubMed ID: 34774107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducible indoleamine 2,3-dioxygenase 1 and programmed death ligand 1 expression as the potency marker for mesenchymal stromal cells.
    Guan Q; Li Y; Shpiruk T; Bhagwat S; Wall DA
    Cytotherapy; 2018 May; 20(5):639-649. PubMed ID: 29548707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indoleamine 2,3-dioxygenase and regulatory T cells in acute myeloid leukemia.
    Mansour I; Zayed RA; Said F; Latif LA
    Hematology; 2016 Sep; 21(8):447-53. PubMed ID: 27077762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-γ regulates the proliferation and differentiation of mesenchymal stem cells via activation of indoleamine 2,3 dioxygenase (IDO).
    Croitoru-Lamoury J; Lamoury FM; Caristo M; Suzuki K; Walker D; Takikawa O; Taylor R; Brew BJ
    PLoS One; 2011 Feb; 6(2):e14698. PubMed ID: 21359206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.